期刊文献+

磷酸西格列汀联合甘精胰岛素对老年2型糖尿病胰岛功能的影响 被引量:3

原文传递
导出
摘要 选取我院2015年1月~2016年2月期间收治的70例老年T_2DM患者为,随机将其分为对照组35例。给予甘精胰岛素治疗,观察组35例在加以磷酸西格列汀治疗。结果观察组HOMA-IR、HOMA-β及空腹C肽水平优于对照组,(P<0.05);治疗后两组HbA_(1c)、FBG及2h PG水平均显著下降,观察组优于对照组(P<0.05);不良反应发生率低于对照组,(P<0.05)。结论老年T2DM患者给予磷酸西格列汀联合甘精胰岛素治疗可有效改善胰岛功能,控制血糖水平。
作者 万红梅
出处 《实用糖尿病杂志》 2017年第3期49-50,共2页 Journal of Practical Diabetology
  • 相关文献

参考文献9

二级参考文献102

  • 1Gerasimos Dimitropoulos,Abd A Tahrani,Martin J Stevens.Cardiac autonomic neuropathy in patients with diabetes mellitus[J].World Journal of Diabetes,2014,5(1):17-39. 被引量:52
  • 2王黎,金晖,孙子林,戴荣峰,卜瑞芳.糖基化终产物对小鼠成骨细胞细胞外基质金属蛋白酶诱导物及基质金属蛋白酶-2分泌的影响[J].中华糖尿病杂志,2009,1(1). 被引量:2
  • 3向红丁.糖尿病的流行病学、诊断分型及防治原则[J].继续医学教育,2005,19(1):28-29. 被引量:26
  • 4Turner RC, Cull CA, Frighi V, et al. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group [ J ]. JAMA, 1999, 281 (21) :2005-2012.
  • 5Brazg R, Xu L, Dalla Man C, et al. Effect of adding sitagliptin, a dipeptidyl peptidase-4 inhibitor, to metformin on 24-h glycaemic control and beta-cell function in patients with type 2 diabetes [ J ]. Diabetes Obes Metab, 2007,9(2) :186-193.
  • 6Baetta R, Corsini A. Pharmacology of dipeptidyl peptidase-.4 inhib- itors : similarities and differences[ J ]. Drugs, 2011,71 ( 11 ) : 1441 - 1467.
  • 7Holst JJ, Gromada J. Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetie humans [ J ]. Am J Physiol Endoerinol Metab, 2004, 287 (2) :E199-E206.
  • 8Kim YS, Oh SH, Park KS, et al. Improved outcome of islet trans- plantation in partially panereateetomized diabetic mice by inhibition of dipeptidyl peptidase-4 with sitagliptin [ J]. Pancreas, 2011, 40(6) :855-860.
  • 9Herman GA, Bergman A, Stevens C, et al. Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes[J]. J Clin Endoefinol Metab, 2006, 91(11) :4612-4619.
  • 10Nauck MA, Meininger G, Sheng D, et al. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sul- fonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-in- feriority trial[J]. Diabetes Obes Metab, 2007,9(2) :194-205.

共引文献208

同被引文献22

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部